selected publications
-
Spotlight on pathogenesis of TRALI: HNA-3a (CTL2) antibodies.
Blood.
2014
Review
GET IT
Times cited: 19 -
Patient blood management: key for accountable care organizations.
JAMA surgery.
2013
Academic Article
GET IT
Times cited: 3 -
Ex vivo generated red cells as transfusion products.
Stem cells international.
2012
Academic Article
GET IT
Times cited: 3 -
Cardiovascular disease risk assessment and prevention in blood donors.
Transfusion.
2012
Academic Article
GET IT
Times cited: 7 -
Demographic differences in estimated blood donor eligibility prevalence in the United States.
Transfusion.
2011
Academic Article
GET IT
Times cited: 24 -
Evaluating the role of blood collection centers in public health: a status report.
Transfusion medicine reviews.
2011
Review
GET IT
Times cited: 6 -
Residual risk of D alloimmunization: is it time to feel safe about platelets from D+ donors?.
Transfusion.
2011
Editorial Article
GET IT
Times cited: 15 -
2-(Diethylhexyl)phthalate in blood bags: is this a public health issue?.
Transfusion.
2011
Review
GET IT
Times cited: 28 -
Is there transfusion-related acute renal injury?.
Anesthesiology.
2010
Editorial Article
GET IT
Times cited: 6 -
Transfusion-related acute lung injury: from bedside to bench and back.
Blood.
2010
Review
GET IT
Times cited: 109 -
Dose of prophylactic platelet transfusions and prevention of hemorrhage.
The New England journal of medicine.
2010
Academic Article
GET IT
Times cited: 479 -
Leukoreduction filtration of blood with sickle cell trait.
Transfusion medicine reviews.
2004
Review
GET IT
Times cited: 31